Product Program year 2025 Source: CMS Open Payments

Apretude

Drug Hiv

NDC 49702-264-23

Open in the dashboard

General payments

$2,376,330

20,428 payments

Research payments

$311,821

38 payments

Through program year 2025, $2,376,330 in general payments and $311,821 in research payments were reported against Apretude (Hiv).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $2,370,392 20,380
2025 Research $311,821 38
2024 General $5,574 41
2023 General $253 6
2022 General $111 1

Breakdown

Who paid General payments · program years 2022–2025
  1. ViiV Healthcare Company $2,376,330 20,428 payments
Top recipients General payments · program year 2025
  1. Zandraetta Tims-Cook Infectious Disease · Atlanta, GA $72,661 3% · 49 payments
  2. Alexea Gaffney-Adams Internal Medicine · E. Setauket, NY $62,822 3% · 42 payments
  3. Ronald Collazo Pagan Internal Medicine · Manati, PR $62,536 3% · 61 payments
  4. Douglas Cunningham Family Medicine · Phoenix, AZ $57,381 2% · 66 payments
  5. Koppany Visnyei Internal Medicine · Los Angeles, CA $50,939 2% · 54 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Internal Medicine $574,984 24% · 730 practitioners
  2. Infectious Disease Internal Medicine $557,668 24% · 545 practitioners
  3. Family Medicine $467,717 20% · 1,049 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $267,062 11% · 1,453 practitioners
  5. Physician Assistant $120,543 5% · 661 practitioners

The top 5 of 129 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $402,585 17% · 1,123 recipients
  2. New York $345,384 15% · 733 recipients
  3. Florida $256,028 11% · 757 recipients
  4. Texas $194,800 8% · 532 recipients
  5. Georgia $153,294 6% · 296 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

588

Prescriptions dispensed, refills included

Drug cost

$2,236,550

Paid at the pharmacy, in all

Prescribers

33

With 11 or more claims of it

Medicare Part D drugs matched to APRETUDE, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Apretude Cabotegravir Same name 33 588 $2,236,550

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 33 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Anna Daymon Nurse Practitioner CA 57 $226,951 $123
Trent Broadus Nurse Practitioner CA 54 $213,986 $280
Alvin Choy Pharmacist OH 29 $102,428 No profile
Dylan Baker Hospitalist GA 22 $81,131 $35
Janet Grochowski Pharmacist CA 22 $78,381 No profile

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 33 with Patron
20,428 general · 38 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record